Atwood & Palmer Inc Regeneron Pharmaceuticals, Inc. Transaction History

Atwood & Palmer Inc

$1.3 Billion
Q2 2024

A detailed history of Atwood & Palmer Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Atwood & Palmer Inc holds 43,859 shares of REGN stock, worth $49.6 Million. This represents 3.54% of its overall portfolio holdings.

Number of Shares

43,859

Previous 43,938 0.18%

Holding current value

$49.6 Million

Previous $42.3 Million 9.0%

% of portfolio

3.54%

Previous 3.24%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$883.2 - $1071.19 $69,772 - $84,624	-79 Reduced 0.18%	43,859 $46.1 Million
Q1 2024 Apr 10, 2024	SELL	$902.69 - $993.35 $483,841 - $532,435	-536 Reduced 1.21%	43,938 $42.3 Million
Q4 2023 Jan 12, 2024	SELL	$775.18 - $881.7 $659,678 - $750,326	-851 Reduced 1.88%	44,474 $39.1 Million
Q3 2023 Oct 20, 2023	SELL	$692.45 - $844.37 $103,867 - $126,655	-150 Reduced 0.33%	45,325 $37.3 Million
Q2 2023 Jul 18, 2023	BUY	$700.03 - $830.35 $2.38 Million - $2.82 Million	3,393 Added 8.06%	45,475 $32.7 Million
Q1 2023 Apr 21, 2023	BUY	$680.49 - $826.97 $61,244 - $74,427	90 Added 0.21%	42,082 $34.6 Million
Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $57,177 - $62,077	81 Added 0.19%	41,992 $30.3 Million
Q3 2022 Oct 12, 2022	BUY	$573.97 - $724.32 $246,233 - $310,733	429 Added 1.03%	41,911 $28.9 Million
Q2 2022 Jul 21, 2022	BUY	$548.35 - $738.84 $236,338 - $318,440	431 Added 1.05%	41,482 $24.5 Million
Q1 2022 Apr 29, 2022	BUY	$595.12 - $698.43 $175,560 - $206,036	295 Added 0.72%	41,051 $28.7 Million
Q4 2021 Jan 24, 2022	BUY	$543.48 - $670.97 $6.77 Million - $8.36 Million	12,454 Added 44.0%	40,756 $25.7 Million
Q3 2021 Oct 19, 2021	BUY	$574.03 - $680.96 $72,327 - $85,800	126 Added 0.45%	28,302 $17.1 Million
Q2 2021 Jul 26, 2021	BUY	$472.8 - $558.54 $13.3 Million - $15.7 Million	28,026 Added 18684.0%	28,176 $15.7 Million
Q1 2021 Apr 26, 2021	BUY	$446.73 - $548.2 $22,336 - $27,410	50 Added 50.0%	150 $71,000
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $11,957 - $15,199	25 Added 33.33%	100 $48,000
Q3 2020 Oct 28, 2020	BUY	$544.75 - $658.21 $40,856 - $49,365	75 New	75 $42,000

Others Institutions Holding REGN

# of Institutions

1,460

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $121B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Account

Atwood & Palmer Inc Regeneron Pharmaceuticals, Inc. Transaction History